160 Health International Limited (HKG:2656)
Hong Kong · Delayed Price · Currency is HKD 8.56
-0.35 (-3.88%)
Sep 11, 2026, 4:08 PM HKT
160 Health International Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 679.95 | 651.87 | 620.68 | 628.61 | 525.65 | |
Revenue Growth | 6.65% | 5.02% | -1.26% | 19.59% | - |
Cost of Revenue | 488.46 | 481.71 | 460.5 | 491.28 | 407.36 |
Gross Profit | 191.49 | 170.16 | 160.19 | 137.33 | 118.29 |
Selling, General & Admin | 202.17 | 201.12 | 210.26 | 191.48 | 137.25 |
Research & Development | 32.95 | 34.96 | 50.51 | 41.7 | 54.06 |
Other Operating Expenses | -3.86 | -3.11 | -3.82 | -4.41 | -7.24 |
Operating Expenses | 241.62 | 243.33 | 265.13 | 236.1 | 184.83 |
Operating Income | -50.13 | -73.18 | -104.94 | -98.77 | -66.55 |
Interest Expense | -8.58 | -6.24 | -3.66 | -11.37 | -40.14 |
Interest & Investment Income | 2.87 | 3.35 | 1.33 | 0.21 | 0.37 |
Currency Exchange Gain (Loss) | -2.1 | -2.1 | 0.42 | -0.33 | - |
Other Non Operating Income (Expenses) | 0.14 | 0.14 | -0.1 | -0.01 | -0.25 |
EBT Excluding Unusual Items | -57.8 | -78.03 | -106.95 | -110.27 | -106.57 |
Gain (Loss) on Sale of Assets | - | - | - | -0.03 | -0 |
Legal Settlements | - | - | - | -0.39 | -12.4 |
Other Unusual Items | 1.2 | 0.7 | -0 | - | 0.02 |
Pretax Income | -56.61 | -77.33 | -106.96 | -110.68 | -118.96 |
Income Tax Expense | -3.38 | -2.8 | 1.29 | 0.55 | - |
Earnings From Continuing Operations | -53.23 | -74.53 | -108.25 | -111.22 | -118.96 |
Earnings From Discontinued Operations | - | - | - | 5.02 | -0.57 |
Net Income to Company | -53.23 | -74.53 | -108.25 | -106.2 | -119.52 |
Minority Interest in Earnings | 1.5 | 1.55 | 0.56 | -2.62 | 8.22 |
Net Income | -51.73 | -72.99 | -107.69 | -108.82 | -111.31 |
Net Income to Common | -51.73 | -72.99 | -107.69 | -108.82 | -111.31 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 309 | 304 | 294 | 291 | 286 |
Shares Outstanding (Diluted) | 309 | 304 | 294 | 291 | 286 |
Shares Change | 4.98% | 3.32% | 1.18% | 1.71% | - |
EPS (Basic) | -0.17 | -0.24 | -0.37 | -0.37 | -0.39 |
EPS (Diluted) | -0.17 | -0.24 | -0.37 | -0.37 | -0.39 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -166.24 | -118.59 | -56.99 | -67.23 | -44.88 |
Free Cash Flow Per Share | -0.54 | -0.39 | -0.19 | -0.23 | -0.16 |
Gross Margin | 28.16% | 26.10% | 25.81% | 21.85% | 22.50% |
Operating Margin | -7.37% | -11.23% | -16.91% | -15.71% | -12.66% |
Profit Margin | -7.61% | -11.20% | -17.35% | -17.31% | -21.18% |
Free Cash Flow Margin | -24.45% | -18.19% | -9.18% | -10.70% | -8.54% |
EBITDA | -47.89 | -70.46 | -101.57 | -94.96 | -63.23 |
EBITDA Margin | -7.04% | -10.81% | -16.36% | -15.11% | -12.03% |
D&A For EBITDA | 2.24 | 2.72 | 3.37 | 3.81 | 3.31 |
EBIT | -50.13 | -73.18 | -104.94 | -98.77 | -66.55 |
EBIT Margin | -7.37% | -11.22% | -16.91% | -15.71% | -12.66% |